Psychedelics Today

In this episode of Psychedelics Today , Joe Moore sits down with Louis Dorian, the visionary behind Psychedelist , a groundbreaking global platform designed to support the emerging psychedelic movement. Described as a "cyber city" for all things psychedelic, Psychedelist connects individuals with treatment providers, educators, facilitators, legal experts, and even vetted product vendors in an eff...

In this episode of Psychedelics Today , Joe Moore is joined by Neeka Levy and Zach Skiles of Heal Ukraine Trauma , a nonprofit bringing psychedelic-assisted therapy to veterans and civilians affected by war. They discuss the organization's origins, the impact of intergenerational trauma in Ukraine, and the evolving role of psychedelic treatments in a war-torn nation. Nika, a first-generation Ukrai...

In this episode, Joe interviews Josh Lipson, a Ph. D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-world settings, the role of metaphysical perspectives in research, and why different individuals respond to psychedelics i...

In this episode, Joe interviews Nico and Susan Simon: Co-founders of JourneyŌM, a concierge service looking to address the question many people are asking: How do you find the right facilitator? Through a dedicated vetting process, JourneyŌM is adding a layer of risk reduction and accountability to this strange new world, by traveling the country and amassing a network of trusted facilitators who...

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris.  After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers stud...

In this episode, Joe interviews Jeremy Falk: certified instructor and training program developer for Kama Flight ; and Dr. David Rabin, MD, Ph. D.: board-certified psychiatrist and neuroscientist, co-founder & chief Medical Officer at Apollo Neuroscience, and advisor to the non-profit, Kama Flight Foundation. Kama Flight is a wellness modality for partners, inspired by the movements of Watsu thera...

In this episode, Joe interviews Ariel Clark: Anishinaabe attorney and co-founder of the Psychedelic Bar Association, a national association of lawyers involved in the highly-regulated ecosystem of psychedelic law. She talks about ethics: How do the different societal norms of each lineage we carry interact with each other? What is the cultural framing that informs those ways of knowing, and do we...

In this episode, Joe interviews Angie Roullier: longtime veteran of the cannabis industry and author of the book, Pot for the People: The Plant, the People, and the Shop Policies of Cannabis . Diagnosed with the neurological disorder, Charcot-Marie-Tooth (CMT), Roullier tells the story of how cannabis replaced all her medications, which led to a personal journey and career centered on cannabis edu...

In this episode, Kyle interviews Tommy Aceto: former Navy Seal and trauma medic, and now, ambassador for the Veteran Mental Health Leadership Coalition and advisor at Beond Ibogaine. He talks about how much the psychedelic space focuses on healing and mental health, but doesn't talk enough about the overall wellness that can come from a consistent practice: that the more you become aware of your b...

In this episode, Joe interviews Melanie Curtis: world record professional skydiver, keynote speaker, coach, co-host of the Trust the Journey podcast, and author of How to Fly: Life Lessons From a Professional Skydiver . Curtis shares her journey from taking her first transformative leap out of an airplane to becoming a leader in skydiving, public speaking, and now, the integration of psychedelics...

In this episode, Joe interviews Dan Ronken: licensed professional counselor and addiction counselor with a private practice in Boulder, CO, called Inclusion Recovery, and lead trainer and facilitator for the Integrative Psychiatry Institute (IPI). He tells his story of going from a sponsored BMX racer to three stints in rehab before the age of 14, and what he's learned from his experiences in reco...

In this episode, Joe interviews Shauheen Etminan, Ph. D.: co-founder of VCENNA, a drug discovery and development company, and Magi Ancestral Supplements, which sells nootropics inspired by ancient Eastern traditions. He discusses his journey into the world of plant extraction, how he first discovered compounds like Haoma and Harmaline, and why he decided to bring Iranian tradition to the psychedel...

In this episode, Joe interviews Paul Grof: research psychiatrist, clinician, author, brother of Stanislav, professor of psychiatry at the University of Toronto, and director of the Ottawa Mood Disorders Center. He talks about his extensive career in psychiatry, and how trying to understand the cause of mood disorders led him to focusing on the very nature of consciousness. He believes that conscio...

In this episode, Joe interviews Kat Murti: executive director of Students for Sensible Drug Policy (SSDP), the largest nationwide network of students fighting to replace the War on Drugs with policies rooted in evidence, compassion, and human rights. She talks about how she became interested in drug policy, which not surprisingly aligns with the many problems of The War on Drugs: how it's a war on...

In this episode, Joe interviews Howard Kornfeld, MD: renowned pain medicine expert, addiction specialist, early pioneer in psychedelic medicine, and currently the director of recovery medicine at Recovery Without Walls. As a leader in the utilization of buprenorphine, he talks about how it came about as a treatment for addiction and chronic pain, its similarities to MDMA, and how its fast-tracked...

In this episode, Joe interviews Veronica Lightning Horse Perez: therapist, speaker, author, activist, and co-chief proponent for the Natural Medicine Health Act of 2022 (Prop 122); and Sean McAllister: attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines, and one of the drafters of Prop 122. This episode was recorded live at the Pla...

In this episode, Joe interviews two members of the Heroic Hearts Project: Founder and President, Jesse Gould; and Director of Development and Head of Family Relations, Allison Wilson. Gould gives a background of Heroic Hearts Project and discusses their current projects and future goals, and Wilson talks about her nonprofit, The Hope Project, and its recent merger with HHP to bring more of a focus...

In this episode, Victoria interviews Max Montrose: Founder of the Trichome Institute, a company offering online courses and certifications on cannabis. Montrose explores the scientific and sensory aspects of cannabis, diving into the role of the aromatic compound, indole, and how the fresher and more aromatic (usually pungent) the flower is, the higher chance for having a more psychedelic experien...

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry.  Bouchard introduces his 3-axis framework for psychedelic integration, which looks at the personal, the transpersonal, and, with time, seeing how the lessons learned from non-ordinary experiences and personal work are expr...

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her personal journey with psychedelics and how they unlocked deep trauma, allowing her to develop a level of comfort with intimacy, love, and her sexuality. She talks about the parallels between psychedeli...

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standards – especially for at-home ketamine – before the...

In this episode, Kyle interviews Geoff Bathje, Ph. D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketamine-assisted therapy and psychedelic integration. He talks about what he feels is one of the largest factors in our mental health crisis: the individualistic and neoliberal lens Western culture has pl...

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for treatment. So he worked to create what was needed: a combination of a hospital, mental health treatment facility, retre...

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, trials, companies, and over 2000 categorized research articles. When Wolswijk began Blossom, he was barely able to fill a weekly newsletter, and now he's adding a new study nearly every day, perfectly il...

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it's legal) to employees. She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years...